The evolution of clinical trials for infant acute lymphoblastic leukemia

by Kotecha, R S, Gottardo, N G, Kees, U R, Cole, C H
Published 2014

Comparative drug screening in NUT midline carcinoma

by Beesley, A H, Stirnweiss, A, Ferrari, E, Endersby, R, Howlett, M, Failes, T W, Arndt, G M, Charles, A K, Cole, C H, Kees, U R
Published 2014

A novel BRD4-NUT fusion in an undifferentiated sinonasal tumor highlights alternative splicing as a contributing oncogenic factor in NUT midline carcinoma

by Stirnweiss, A, McCarthy, K, Oommen, J, Crook, M L, Hardy, K, Kees, U R, Wilton, S D, Anazodo, A, Beesley, A H
Published 2015

A pre-clinical model of resistance to induction therapy in pediatric acute lymphoblastic leukemia

by Samuels, A L, Beesley, A H, Yadav, B D, Papa, R A, Sutton, R, Anderson, D, Marshall, G M, Cole, C H, Kees, U R, Lock, R B
Published 2014

Silencing of GATA3 defines a novel stem cell-like subgroup of ETP-ALL

by Fransecky, L., Neumann, M., Heesch, S., Schlee, C., Ortiz-Tanchez, J., Heller, S., Mossner, M., Schwartz, S., Mochmann, L. H., Isaakidis, K., Bastian, L., Kees, U. R., Herold, T., Spiekermann, K., Gökbuget, N., Baldus, C. D.
Published 2016